Log in

Natco's correction is overdone. Buy for TP ₹1305 (50% upside)

Discussion in 'Latest Brokerage Stock Buy-Sell Reports' started by Vidhi Khanna, Feb 17, 2025.

Tags:

Previous Thread Next Thread

Loading...

Vidhi Khanna Active Member Staff Member

Joined:

Mar 19, 2015

Messages:

961

Likes Received:

55

Natco's correction is overdone. It has a knack for manufacturing complex generic products with few competitors & focus on blockbusters which are capable of generating robust cash flows for 3-5 years horizon before they fade. Buy for TP ₹1305 (50% upside)

Download research report

Vidhi Khanna, Feb 17, 2025

#1

Previous Thread Next Thread

Loading...

(You must log in or sign up to reply here.)

Loading...

Similar Threads

Raymond Lifestyle's valuation, after the correction, appears attractive. TP ₹1500 (+49%)

Vidhi Khanna, May 14, 2025, in forum: Latest Brokerage Stock Buy-Sell Reports

Replies:

0

Views:

364

Vidhi Khanna

May 14, 2025
ABDL is 3rd largest IMFL Co in terms of sales volumes. Valuations are attractive post correction.

Vidhi Khanna, Mar 24, 2025, in forum: Latest Brokerage Stock Buy-Sell Reports

Replies:

0

Views:

313

Vidhi Khanna

Mar 24, 2025
Landmark cars' correction in stock price offers attractive risk-reward play

Vidhi Khanna, Mar 1, 2025, in forum: Latest Brokerage Stock Buy-Sell Reports

Replies:

0

Views:

285

Vidhi Khanna

Mar 1, 2025
Solar Industries' stock price correction provides a good entry point. Target price ₹13720 (+55%)

Vidhi Khanna, Feb 24, 2025, in forum: Latest Brokerage Stock Buy-Sell Reports

Replies:

0

Views:

387

Vidhi Khanna

Feb 24, 2025
Concord Biotech is a good buy after 30% correction. Jhunjhunwala holds stock in portfolio

Vidhi Khanna, Nov 16, 2024, in forum: Portfolios Of Famous Investors

Replies:

0

Views:

944

Vidhi Khanna

Nov 16, 2024

Search